[The preventive efficacy of bioparox in children with chronic tonsillitis].
Garashchenko
T I
TI
Garashchenko
M V
MV
Kubylinskaia
I A
IA
Ovechkina
N V
NV
Kats
T G
TG
D000287:Administration, Topical; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002648:Child; D002908:Chronic Disease; D047630:Depsipeptides; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D005670:Fusarium; D006801:Humans; D008297:Male; D055502:Secondary Prevention; D014069:Tonsillitis / Q000517:prevention & control*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D047630:Depsipeptides; C014001:fusafungin